Monosaccharide profiling by intact mass analysis - method qualification of a new approach for the characterization of highly glycosylated biopharmaceuticals


The development and production of recombinant biosimilars is a challenging field due to their structural complexity. When implementing a manufacturing process for biosimilars, differences in the protein structure or post-translational modifications can occur. Therefore a characterization program is required following the biosimilar guidelines. Of great interest are protein glycosylations which can have a great influence on efficacy and safety of the biopharmaceutical. Glycosylations are usually analyzed after isolation from the protein by HPAEC-PAD or HILIC-FLD. Alternatively, LC-ESI-MS analysis of the intact protein can be employed to yield the glycosylation pattern or monosaccharide profile. Here, we analyzed Ustekinumab, Erythropoietin, and Etanercept with an UHR-TOF mass spectrometer. The method was qualified by comparison to data achieved by HILIC-FLD and HPAEC-PAD.

Hosted By

The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo Follow us on Twitter

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
Eventflo Home
copyright ELRIG,, Labhoo Ltd 2003-2021